CSF biomarker variability in the Alzheimer's Association quality control program
…, LM Shaw, C Sisowath, A Skinningsrud… - Alzheimer's & …, 2013 - Wiley Online Library
Background The cerebrospinal fluid (CSF) biomarkers amyloid beta 1–42, total tau, and
phosphorylated tau are used increasingly for Alzheimer's disease (AD) research and patient …
phosphorylated tau are used increasingly for Alzheimer's disease (AD) research and patient …
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers
…, J Schröder, LM Shaw, A Skinningsrud… - Alzheimer's & …, 2011 - Wiley Online Library
Background The cerebrospinal fluid (CSF) biomarkers amyloid β (Aβ)‐42, total‐tau (T‐tau),
and phosphorylated‐tau (P‐tau) demonstrate good diagnostic accuracy for Alzheimer's …
and phosphorylated‐tau (P‐tau) demonstrate good diagnostic accuracy for Alzheimer's …
Validation of 14-3-3 protein as a marker in sporadic Creutzfeldt-Jakob disease diagnostic
…, R Sanchez-Valle, A Ladogana, A Skinningsrud… - Molecular …, 2016 - Springer
At present, the testing of 14-3-3 protein in cerebrospinal fluid (CSF) is a standard biomarker
test in suspected sporadic Creutzfeldt-Jakob disease (sCJD) diagnosis. Increasing 14-3-3 …
test in suspected sporadic Creutzfeldt-Jakob disease (sCJD) diagnosis. Increasing 14-3-3 …
Serum ferritin and transferrin saturation in patients with chronic alcoholic and non‐alcoholic liver diseases
H Bell, A Skinningsrud, N Raknerud… - Journal of internal …, 1994 - Wiley Online Library
Objectives. To compare serum ferritin concentration and transferrin saturation in patients with
alcoholic and non‐alcoholic chronic liver diseases. Design. Concecutive patients with liver …
alcoholic and non‐alcoholic chronic liver diseases. Design. Concecutive patients with liver …
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease
…, T Pirttila, L Saleh, A Skinningsrud… - Annals of clinical …, 2009 - journals.sagepub.com
Background Different cerebrospinal fluid (CSF) amyloid-beta 1–42 (Aβ 1–42 ), total Tau (Tau)
and Tau phosphorylated at threonine 181 (P-Tau) levels are reported, but currently there is …
and Tau phosphorylated at threonine 181 (P-Tau) levels are reported, but currently there is …
Mild cognitive impairment: cerebrospinal fluid tau biomarker pathologic levels and longitudinal changes in white matter integrity
…, A Bjørnerud, P Due-Tønnessen, A Skinningsrud… - Radiology, 2013 - pubs.rsna.org
Purpose To evaluate the relationship between (a) pathologic levels of cerebrospinal fluid (CSF)
total tau as an index of the intensity of ongoing neuronal degeneration and (b) …
total tau as an index of the intensity of ongoing neuronal degeneration and (b) …
[HTML][HTML] Cerebrospinal fluid markers in Creutzfeldt-Jakob disease
A Skinningsrud, V Stenset, AS Gundersen… - Cerebrospinal Fluid …, 2008 - Springer
Background The objective was to assess the utility of total tau protein (tTau), the ratio of (tTau)/181
phosphorylated tau protein (P-Tau) and 14-3-3 protein, as diagnostic markers in …
phosphorylated tau protein (P-Tau) and 14-3-3 protein, as diagnostic markers in …
Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment
…, R Grambaite, A Skinningsrud… - American Journal …, 2008 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Mild cognitive impairment (MCI) may affect several cognitive
domains, including attention and reasoning, but is often first characterized by memory …
domains, including attention and reasoning, but is often first characterized by memory …
Associations between white matter lesions, cerebrovascular risk factors, and low CSF Aβ42
…, L Johnsen, D Kocot, A Negaard, A Skinningsrud… - Neurology, 2006 - AAN Enterprises
Objective: To analyze a putative relationship between white matter lesions (WMLs), risk factors
for WMLs, and Alzheimer disease (AD) as measured with the surrogate marker CSF Aβ42…
for WMLs, and Alzheimer disease (AD) as measured with the surrogate marker CSF Aβ42…
[HTML][HTML] Perinatal asphyxia may influence the level of beta-amyloid (1-42) in cerebrospinal fluid: an experimental study on newborn pigs
…, L Pankratov, R Solberg, N Bolstad, A Skinningsrud… - PLoS …, 2015 - journals.plos.org
Objective Total tau (T-tau), phosphorylated tau (p-Tau) and Beta-Amyloid 1–42 (AB42) in
Cerebrospinal Fluid (CSF) are useful biomarkers in neurodegenerative diseases. The aim of …
Cerebrospinal Fluid (CSF) are useful biomarkers in neurodegenerative diseases. The aim of …